Carrizo, Edgardo <br/><br/>
Extended release metformin for metabolic control assistance during prolonged clozapine administration: a 14 week, double-blind, parallel group, placebo-controlled study.  [electronic resource] 

 -  Schizophrenia research  Aug 2009 
 - 19-26 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1573-2509 
<br/><br/><label>Standard No.: </label>10.1016/j.schres.2009.05.007  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Anthropometry--methods<br/>Antipsychotic Agents--administration & dosage<br/>Blood Glucose--drug effects<br/>Blood Pressure--drug effects<br/>Body Mass Index<br/>Body Weight--drug effects<br/>Cholesterol, HDL--blood<br/>Clozapine--administration & dosage<br/>Double-Blind Method<br/>Drug Delivery Systems--methods<br/>Enzyme-Linked Immunosorbent Assay--methods<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Hydrocortisone--blood<br/>Hypoglycemic Agents--pharmacology<br/>Insulin--blood<br/>Insulin Resistance<br/>Leptin--blood<br/>Male<br/>Metformin--pharmacology<br/>Middle Aged<br/>Schizophrenia--blood<br/>Statistics, Nonparametric<br/>Waist Circumference--drug effects